Table II.
Correction N=35 |
No correction N=37 |
P-value | |
---|---|---|---|
Prolonged PT, N (%) | 19 (54) | 22 (59) | 0.66 |
PT, seconds, mean±SD* | 16.0±1.2 | 16.6±1.1 | 0.39 |
Low platelet count, N (%) | 13 (37) | 10 (27) | 0.36 |
Platelet count, ×109/L, median (IQR)* | 81 [63–85] | 56 [47–70] | 0.03 |
Active treatment with acetylsalicylic acid, N (%) | 11 (31) | 12 (32) | 0.93 |
>1 coagulation disorder present, N (%) | 8 (23) | 7 (19) | 0.68 |
Decrease in PT after transfusion, seconds, mean±SD | |||
1 unit of plasma (N=17) | 0.40±0.56 | - | - |
2 units of plasma (N=1) | 1.4 (−) | - | - |
Increase in platelet count after transfusion,x109/L, median [IQR] | |||
5 units of platelets (N=23) | 35 [11–47] | - | - |
Legend: PT, Prothrombin time;
Only patients who had a prolonged PT or low platelet count are included in the calculation of means/medians